<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Macrocephaly in infants and children: Etiology and evaluation</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Macrocephaly in infants and children: Etiology and evaluation</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Macrocephaly in infants and children: Etiology and evaluation</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Julie A Boom, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jan E Drutz, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Helen V Firth, DM, FRCP, FMedSci</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 20, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The measurement of head circumference (also called occipitofrontal circumference [OFC]) is a direct reflection of head growth and an important step in the evaluation of childhood growth and development.</p><p>The etiology and evaluation of macrocephaly in infants and children will be discussed here. The etiology and evaluation of microcephaly are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2839.html" rel="external">"Microcephaly in infants and children: Etiology and evaluation"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">MONITORING HEAD GROWTH</span><span class="headingEndMark"> — </span>Head growth is affected by growth and alterations in the contents of the cranium (eg, brain, blood, cerebrospinal fluid [CSF], and bone) and the timing of these changes in relation to closure of the fontanelles and sutures. Changes in the volume of any component before the closure of the fontanelles and sutures may alter the occipitofrontal circumference (OFC). In contrast, changes in volume that occur after closure of the fontanelles and sutures bring about compensatory changes in the other components. (See  <a class="medical medical_review" href="/z/d/html/2869.html" rel="external">"The pediatric physical examination: HEENT", section on 'Anterior and posterior fontanelles'</a>.)</p><p>OFC should be measured in all children at health maintenance visits between birth and three years of age. OFC should also be measured at each visit in children of all ages with neurologic or developmental complaints. Deviations from normal head growth may be the first indication of an underlying congenital, genetic, or acquired problem (eg, congenital infection, genetic syndrome, hydrocephalus, intracranial hemorrhage, storage disease, or neoplasm) [<a href="#rid1">1-4</a>]. Many genetic conditions are associated with an abnormal pattern of head growth; the earlier these conditions are detected, the earlier appropriate treatment, services, and genetic counseling can be provided [<a href="#rid5">5</a>].</p><p>The technique for measuring head circumference  (<a class="graphic graphic_picture graphicRef70799" href="/z/d/graphic/70799.html" rel="external">picture 1</a>) is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2865.html" rel="external">"The pediatric physical examination: General principles and standard measurements", section on 'Head circumference'</a>.)</p><p>OFC measurements are most informative when plotted over time [<a href="#rid6">6</a>]. Normal head growth in infants and children and reference standards for monitoring head growth in healthy children are discussed separately. In the United States, the Centers for Disease Control and Prevention (CDC) recommend that the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.who.int%2Ftoolkits%2Fchild-growth-standards%2Fstandards&amp;token=mr3MkQMxxRm373pPGLTYB6lEv8T2h1BSRo3qIw7gt38Q057dFRQVJ89Vy4aOBmJF8XlYlyWxepnTr9ASr67UNw%3D%3D&amp;TOPIC_ID=2849" target="_blank">World Health Organization growth standards</a> ( (<a class="graphic graphic_figure graphicRef58632 graphicRef74503" href="/z/d/graphic/58632.html" rel="external">figure 1A-B</a>) and (<a class="calc calc_professional" href="/z/d/html/15630.html" rel="external">calculator 1</a>)) be used for children age zero to two years and the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fgrowthcharts%2Fcdc_charts.htm&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLMtEcNWPM8WxZItFO808GkzUyw1gyf1LadKIGm99AkTi6m4mxc5JY8HjMjDSva9IOg%3D%3D&amp;TOPIC_ID=2849" target="_blank">CDC growth charts</a> ( (<a class="graphic graphic_figure graphicRef80863 graphicRef59076" href="/z/d/graphic/80863.html" rel="external">figure 2A-B</a>) and (<a class="calc calc_professional" href="/z/d/html/13417.html" rel="external">calculator 2</a>)) be used for children age two to three years [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/2845.html" rel="external">"Normal growth patterns in infants and prepubertal children", section on 'Head growth'</a> and  <a class="medical medical_review" href="/z/d/html/2865.html" rel="external">"The pediatric physical examination: General principles and standard measurements", section on 'Head circumference'</a>.)</p><p class="headingAnchor" id="H5"><span class="h1">DEFINITIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Macrocephaly is defined as an occipitofrontal circumference greater than two standard deviations above the mean for a given age, sex, and gestation (ie, ≥97<sup>th</sup> percentile) [<a href="#rid5">5,8,9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Megalencephaly (also called macrencephaly) is enlargement of the brain parenchyma [<a href="#rid10">10</a>].</p><p></p><p class="headingAnchor" id="H6"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>Macrocephaly is caused by an increase in size of any of the components of the cranium (brain, cerebrospinal fluid [CSF], blood, or bone) or can be attributable to increased intracranial pressure (ICP)  (<a class="graphic graphic_table graphicRef65812" href="/z/d/graphic/65812.html" rel="external">table 1</a>) [<a href="#rid5">5,6,11</a>]. The most common causes of macrocephaly vary with age of onset  (<a class="graphic graphic_table graphicRef74157" href="/z/d/graphic/74157.html" rel="external">table 2</a>). Familial megalencephaly appears to be the most common etiology of mild macrocephaly, especially if the child has normal development [<a href="#rid12">12-15</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Increased brain parenchyma</span><span class="headingEndMark"> — </span>Megalencephaly is classified as anatomic or metabolic [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H8"><span class="h3">Anatomic megalencephaly</span><span class="headingEndMark"> — </span>Anatomic megalencephaly is caused by an increase in the size or number of brain cells in the absence of metabolic disease or acute encephalopathy [<a href="#rid5">5,6,16</a>]. Anatomic megalencephaly is usually present at birth [<a href="#rid11">11</a>]. Postnatally, the occipitofrontal circumference (OFC) continues to be increased and to progress along a trajectory parallel to the upper growth curve percentiles.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Familial megalencephaly</strong> – The most common type of anatomic megalencephaly is benign familial megalencephaly (also called genetic megalencephaly) [<a href="#rid12">12-15</a>]. Children with familial megalencephaly are born with large heads and normal body size. During infancy, OFC increases to greater than the 90<sup>th</sup> percentile, typically 2 to 4 cm (0.8 to 1.5 inches) above, but parallel to, the 98<sup>th</sup> percentile [<a href="#rid5">5,6</a>]. The OFC may increase by 0.6 to 1 cm (0.2 to 0.4 inches) per week (compared with the normal 0.4 cm [0.15 inches] per week) [<a href="#rid13">13,16</a>]. Head growth velocity slows to a normal rate by approximately six months of age [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent1">In children with a normal neurologic examination, normal development, no clinical features suggestive of a specific syndrome, and no family history of abnormal neurologic or developmental problems, familial megalencephaly can be confirmed by measuring the patient's parents' head circumferences and by using Weaver curves [<a href="#rid5">5,17</a>]. If the child's OFC falls within the normal ranges as estimated using the Weaver curves, neuroimaging is not necessary. (See <a class="local">'Assessment of familial macrocephaly'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other causes of anatomic megalencephaly</strong> – Other disorders associated with anatomic megalencephaly include  (<a class="graphic graphic_table graphicRef65812" href="/z/d/graphic/65812.html" rel="external">table 1</a>) [<a href="#rid6">6,8,11</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neurocutaneous disorders (eg, neurofibromatosis, tuberous sclerosis complex, linear sebaceous nevus syndrome, and hypomelanosis of Ito)  (<a class="graphic graphic_table graphicRef75193" href="/z/d/graphic/75193.html" rel="external">table 3</a>) – (See  <a class="medical medical_review" href="/z/d/html/2939.html" rel="external">"Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6175.html" rel="external">"Tuberous sclerosis complex: Clinical features"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Autism spectrum disorder (ASD) – Macrocephaly, accelerated head growth during the first year of life, and megalencephaly may be associated with ASD. Children with ASD have associated impairments in socialization, communication, and behavior. (See  <a class="medical medical_review" href="/z/d/html/627.html" rel="external">"Autism spectrum disorder in children and adolescents: Clinical features", section on 'Macrocephaly'</a>.)</p><p></p><p class="bulletIndent2">Some children with ASD and macrocephaly may have germline <em>PTEN</em> mutations. (See  <a class="medical medical_review" href="/z/d/html/16543.html" rel="external">"PTEN hamartoma tumor syndromes, including Cowden syndrome", section on 'Autism spectrum disorders and macrocephaly'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Achondroplasia – Achondroplasia is the most frequent form of short-limbed dwarfism  (<a class="graphic graphic_picture graphicRef80450 graphicRef66831" href="/z/d/graphic/80450.html" rel="external">picture 2A-B</a>). In addition to megalencephaly, children with achondroplasia also may develop hydrocephalus. (See  <a class="medical medical_review" href="/z/d/html/103825.html" rel="external">"Achondroplasia"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cerebral gigantism (Sotos syndrome) – <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F117550&amp;token=87jLzclRwWxNoI%2BQq5Gg71rPI%2FO9hPnU0IL2nlvGn1gHgzsj5dp5FQIGwXWWMes8&amp;TOPIC_ID=2849" target="_blank">Cerebral gigantism</a> is an overgrowth syndrome with prenatal onset. In addition to megalencephaly, children with cerebral gigantism also may develop hydrocephalus [<a href="#rid18">18</a>]. (See  <a class="medical medical_review" href="/z/d/html/5848.html" rel="external">"The child with tall stature and/or abnormally rapid growth", section on 'Cerebral gigantism'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fragile X syndrome – <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F300624&amp;token=87jLzclRwWxNoI%2BQq5Gg7%2Bwk%2FhcgjSrHDDiukJJuLXzdC3UK73W1D%2BLseQylePcP&amp;TOPIC_ID=2849" target="_blank">Fragile X syndrome</a> is the most common form of familial intellectual disability in males. The OFC percentile is usually greater than the weight and height percentiles but may not be more than two standard deviations above the mean. Characteristic features (which typically are mild or absent before puberty) include a long face, large ears, prominent jaw, and macro-orchidism. (See  <a class="medical medical_review" href="/z/d/html/2924.html" rel="external">"Fragile X syndrome: Clinical features and diagnosis in children and adolescents"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cowden syndrome – <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F158350&amp;token=87jLzclRwWxNoI%2BQq5Gg789VELhuCit5a71oJTyPIzrCfTb3grcqrbZ30iY3y2To&amp;TOPIC_ID=2849" target="_blank">Cowden syndrome</a> is an autosomal dominant cancer predisposition syndrome that is caused by mutations in the <em>PTEN</em> gene. Affected individuals have an increased risk for thyroid malignancy, and females have a risk for early breast cancer. (See  <a class="medical medical_review" href="/z/d/html/16543.html" rel="external">"PTEN hamartoma tumor syndromes, including Cowden syndrome", section on 'Cowden syndrome'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nevoid basal cell carcinoma syndrome (also called Gorlin syndrome) – <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F109400&amp;token=87jLzclRwWxNoI%2BQq5Gg7wZhcaiuBwPB8L%2FtD%2Fk%2ByeBuIFOkKhoXYvObxfkDnDzf&amp;TOPIC_ID=2849" target="_blank">Nevoid basal cell carcinoma syndrome</a> is an autosomal dominant syndrome that predisposes to basal cell carcinoma (BCC) during adolescence and young adulthood. Affected individuals have a large OFC, "coarse" facial features (eg, prominent forehead, hypertelorism, widened nasal bridge, and mandibular prognathism), jaw cysts, and palmar/plantar pits. It is caused by mutations in the <em>PTCH1</em> gene. (See  <a class="medical medical_review" href="/z/d/html/5340.html" rel="external">"Nevoid basal cell carcinoma syndrome (Gorlin syndrome)"</a>.)</p><p></p><p class="headingAnchor" id="H9"><span class="h3">Metabolic megalencephaly</span><span class="headingEndMark"> — </span>The deposition of metabolic products in the brain tissue causes metabolic megalencephaly [<a href="#rid5">5,16,19</a>]. The OFC of children with metabolic megalencephaly is usually within the normal range at the time of birth but increases during the neonatal period [<a href="#rid6">6,11</a>].</p><p>Examples of diseases that cause metabolic megalencephaly include leukodystrophies (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F203450&amp;token=87jLzclRwWxNoI%2BQq5Gg795PE3zyb%2BTTOa1YB3j1xZ32CUQMZUsim3FDVrjlXSal&amp;TOPIC_ID=2849" target="_blank">Alexander disease</a>, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F271900&amp;token=87jLzclRwWxNoI%2BQq5Gg797JnfSBqo2IC1TW2y%2F6n9aLF9epR4cQNOIvGD9XFOiH&amp;TOPIC_ID=2849" target="_blank">Canavan disease</a>, megalencephalic leukoencephalopathy), lysosomal diseases (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F272800&amp;token=87jLzclRwWxNoI%2BQq5Gg7%2B6xfaVZcE5XhOmENiMWh%2F68Ez0t6zWcaecAkQb2Js7T&amp;TOPIC_ID=2849" target="_blank">Tay-Sachs disease</a>, mucopolysaccharidosis, and gangliosidosis), and organic acid disorders (eg, glutaric aciduria type 1)  (<a class="graphic graphic_table graphicRef65812" href="/z/d/graphic/65812.html" rel="external">table 1</a>) [<a href="#rid5">5,6,10,20</a>].</p><p class="headingAnchor" id="H10"><span class="h2">Increased cerebrospinal fluid</span></p><p class="headingAnchor" id="H11"><span class="h3">Hydrocephalus</span><span class="headingEndMark"> — </span>Hydrocephalus is a disorder in which the cerebral ventricular system contains an excessive amount of CSF, resulting in increased pressure and dilatation. Hydrocephalus may be caused by increased production, decreased absorption, or obstruction to CSF flow. Hydrocephalus is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6174.html" rel="external">"Hydrocephalus in children: Physiology, pathogenesis, and etiology"</a> and  <a class="medical medical_review" href="/z/d/html/110031.html" rel="external">"Hydrocephalus in children: Clinical features and diagnosis"</a>.)</p><p>Increased OFC is frequently the presenting sign of hydrocephalus  (<a class="graphic graphic_figure graphicRef82118" href="/z/d/graphic/82118.html" rel="external">figure 3</a>). In a retrospective cohort of 298 children &lt;5 years of age who were hospitalized for intracranial expansion, hydrocephalus was the main diagnosis in 173 (58 percent) [<a href="#rid21">21</a>]. Approximately three-fourths of the children with hydrocephalus were referred for increasing OFC; other signs and symptoms included nausea/vomiting, irritability, delayed development, and aberrant head shape [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H12"><span class="h3">Benign enlargement of the subarachnoid space</span><span class="headingEndMark"> — </span>Benign enlargement of the subarachnoid space (also called benign extra-axial fluid, idiopathic external hydrocephalus, extraventricular hydrocephalus, and benign subdural effusion) is another cause of macrocephaly [<a href="#rid22">22-25</a>].</p><p>Benign enlargement of the subarachnoid space is relatively common, accounting for 16 percent of infants with macrocephaly in one case series [<a href="#rid26">26</a>]. In population-based surveillance in Norway, the incidence of benign enlargement of the subarachnoid space was 0.4 per 1000 live births [<a href="#rid27">27</a>]. It is more common in males than in females and frequently has occurred or occurs in other family members [<a href="#rid5">5,22,27,28</a>]. Macrocephaly may or may not be present at birth; if it is not present at birth, the OFC rapidly increases to greater than the 95<sup>th</sup> percentile and then tends to parallel the curve [<a href="#rid6">6,22,29,30</a>]. The head growth velocity typically slows to normal by the time the child reaches six months of age [<a href="#rid5">5</a>].</p><p>Imaging is necessary to make the diagnosis. Head ultrasonography, magnetic resonance imaging (MRI), or computed tomography (CT) scan demonstrates enlargement of the subarachnoid space in the frontal or frontoparietal areas with a prominent interhemispheric fissure and normal ventricles  (<a class="graphic graphic_diagnosticimage graphicRef111489" href="/z/d/graphic/111489.html" rel="external">image 1</a>) [<a href="#rid6">6,22</a>]. The anterior location of the fluid collection distinguishes benign enlargement of the subarachnoid space from cerebral atrophy, in which the fluid collection is distributed anteriorly and posteriorly [<a href="#rid24">24</a>].</p><p>Children who were born at term and have enlargement of the subarachnoid space typically have normal development and normal neurologic examinations, though there are exceptions [<a href="#rid22">22,26,29-36</a>]. These children should be observed closely for developmental or neurologic problems. OFC measurements should be plotted monthly for six months to be certain that head growth slows to a normal rate and begins to parallel the normal curve [<a href="#rid5">5</a>]. Repeat imaging is unnecessary unless head growth deviates from the normal curve, the neurologic examination is abnormal, or the development is delayed [<a href="#rid6">6,36</a>]. (See <a class="local">'Neuroimaging'</a> below.)</p><p>Children with benign enlargement of the subarachnoid space usually do not require surgical intervention [<a href="#rid36">36</a>]. However, they may be at increased risk for subdural hematoma with minimal or no trauma [<a href="#rid37">37,38</a>]. (See  <a class="medical medical_review" href="/z/d/html/6520.html" rel="external">"Intracranial subdural hematoma in children: Epidemiology, anatomy, and pathophysiology"</a> and  <a class="medical medical_review" href="/z/d/html/6534.html" rel="external">"Intracranial subdural hematoma in children: Clinical features, evaluation, and management"</a>.)</p><p>"Benign" enlargement of the subarachnoid space should be distinguished from extra-axial fluid collections that occur in survivors of the neonatal intensive care unit and/or extracorporeal membrane oxygenation. Macrocephaly and extra-axial fluid in these children are associated with adverse neurologic and developmental outcomes [<a href="#rid39">39-41</a>]. The relative contributions of the extra-axial fluid, medical problems, and/or complications of therapy to the adverse outcome are not clear.</p><p class="headingAnchor" id="H13"><span class="h2">Increased blood</span><span class="headingEndMark"> — </span>Increased intracranial blood volume may be caused by hemorrhage (intraventricular, subdural, epidural) or arteriovenous malformation. (See  <a class="medical medical_review" href="/z/d/html/6520.html" rel="external">"Intracranial subdural hematoma in children: Epidemiology, anatomy, and pathophysiology"</a> and  <a class="medical medical_review" href="/z/d/html/6534.html" rel="external">"Intracranial subdural hematoma in children: Clinical features, evaluation, and management"</a>.)</p><p>Increased OFC is rarely the sole manifestation of intracranial hemorrhage. In a retrospective cohort of 298 children &lt;5 years of age who were hospitalized for intracranial expansion, intracranial bleeding was the main diagnosis in 35 (12 percent) [<a href="#rid21">21</a>]. Increased OFC was the presenting sign in only two; more common presentations included irritability, seizures, nausea/vomiting, fatigue/drowsiness, and paresis.</p><p class="headingAnchor" id="H14"><span class="h2">Increased bone</span><span class="headingEndMark"> — </span>Bone thickening, a rare cause of macrocephaly, can occur from bone marrow expansion, as seen in thalassemia major, or primary bone disorders (eg, skeletal and cranial dysplasias)  (<a class="graphic graphic_table graphicRef65812" href="/z/d/graphic/65812.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H15"><span class="h2">Increased intracranial pressure</span><span class="headingEndMark"> — </span>Increased ICP may be idiopathic (ie, pseudotumor cerebri) or caused by increased volume of the intracranial contents (eg, brain, CSF, blood, mass lesions), infection, inflammation, and various toxic or metabolic abnormalities (eg, lead poisoning, vitamin A deficiency or excess, galactosemia). (See  <a class="medical medical_review" href="/z/d/html/5257.html" rel="external">"Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6077.html" rel="external">"Elevated intracranial pressure (ICP) in children: Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H16"><span class="h3">Mass lesions</span><span class="headingEndMark"> — </span>Intracranial mass lesions include intracranial cysts, tumors, or abscesses [<a href="#rid8">8</a>]. Increased OFC is rarely the sole manifestation of intracranial tumor.</p><p>In a retrospective cohort of 298 children &lt;5 years of age who were hospitalized for intracranial expansion, tumor was the main diagnosis in57 (19 percent) [<a href="#rid21">21</a>]. Increased OFC was the presenting sign in only three; more common presentations included nausea/vomiting, unsteadiness, headache, fatigue, torticollis, and irritability.</p><p>In the same cohort, intracranial cyst was the main diagnosis in 29 children (10 percent); increased OFC was the most frequent presenting sign (in nine patients); other symptoms included seizures, headache, and nausea/vomiting. (See  <a class="medical medical_review" href="/z/d/html/6250.html" rel="external">"Clinical manifestations and diagnosis of central nervous system tumors in children"</a>.)</p><p class="headingAnchor" id="H482317963"><span class="h1">EVALUATION OF POSTNATAL MACROCEPHALY</span></p><p class="headingAnchor" id="H18"><span class="h2">Overview of approach</span><span class="headingEndMark"> — </span>Evaluation for macrocephaly should be initiated when [<a href="#rid19">19,29,42</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A single occipitofrontal circumference (OFC) measurement is abnormal, or</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Serial measurements reveal progressive enlargement (ie, crossing of one or more major percentile lines [eg, 10<sup>th</sup>, 25<sup>th</sup>, 50<sup>th</sup>, 75<sup>th</sup>, 90<sup>th</sup>] between health supervision visits), or</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For infants age &lt;6 months, there is an increase in OFC of &gt;2 cm (0.8 inches) per month</p><p></p><p>It is important to verify the measurement; isolated deviant measurements often are due to technical error.</p><p>The evaluation of macrocephaly includes a thorough history and physical examination of the child and parents (in consideration of familial variation in head size). Additional evaluation, which is directed by clinical findings from the history and examination, may include neuroimaging and other tests  (<a class="graphic graphic_algorithm graphicRef117172" href="/z/d/graphic/117172.html" rel="external">algorithm 1</a>). (See <a class="local">'Other tests'</a> below and <a class="local">'Neuroimaging'</a> below.)</p><p>Factors that increase the urgency and extent of the imaging and laboratory evaluation include [<a href="#rid10">10,29</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Whether the fontanelles remain open</p><p class="bulletIndent1"><span class="glyph">●</span>History of central nervous system (CNS) trauma or infection</p><p class="bulletIndent1"><span class="glyph">●</span>Associated symptoms (eg, headache, ataxia), neurodevelopmental abnormalities, or syndromic features</p><p class="bulletIndent1"><span class="glyph">●</span>Family history of neurologic or cutaneous abnormalities</p><p></p><p class="headingAnchor" id="H19"><span class="h3">Elevated ICP, CNS trauma, or CNS infection</span><span class="headingEndMark"> — </span>Urgent evaluation is necessary if there are symptoms or signs of increased intracranial pressure (ICP) (eg, headache, vomiting, altered mental status, bulging fontanelle, papilledema), CNS trauma, or CNS infection (eg, fever, meningismus, lethargy, irritability). (See  <a class="medical medical_review" href="/z/d/html/6077.html" rel="external">"Elevated intracranial pressure (ICP) in children: Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H20"><span class="h3">Syndromic features</span><span class="headingEndMark"> — </span>Consultation with, or referral to, a clinical geneticist should be initiated to determine the appropriate diagnostic evaluation if the child has syndromic features  (<a class="graphic graphic_table graphicRef75193" href="/z/d/graphic/75193.html" rel="external">table 3</a>). (See <a class="local">'Other tests'</a> below.)</p><p class="headingAnchor" id="H21"><span class="h3">Developmental delay</span><span class="headingEndMark"> — </span>If syndromic features are absent and the child has developmental delay, neuroimaging (usually with MRI or CT) is warranted. Neuroimaging may reveal abnormalities consistent with a particular etiology (eg, hydrocephalus, leukodystrophy, gangliocytoma in <em>PTEN</em> hamartoma syndrome) [<a href="#rid10">10</a>]. (See <a class="local">'Neuroimaging'</a> below.)</p><p>If neuroimaging is normal in a child with delayed development, referral to a developmental pediatrician, clinical geneticist, or pediatric neurologist, and the initiation of diagnostic testing may be indicated. The differential diagnosis includes autism spectrum disorder (ASD), metabolic disorders, microduplication syndromes, and microdeletion syndromes [<a href="#rid10">10</a>]. (See <a class="local">'Other tests'</a> below.)</p><p class="headingAnchor" id="H22"><span class="h3">Normal development</span><span class="headingEndMark"> — </span>If syndromic features are absent, the degree of macrocephaly is modest, and development is normal, the OFC of first-degree relatives (parents, siblings) should be measured to assess for familial macrocephaly [<a href="#rid10">10</a>]. Ultrasonography of the head may be undertaken in infants with an open fontanelle. (See <a class="local">'Assessment of familial macrocephaly'</a> below and <a class="local">'Neuroimaging'</a> below.)</p><p class="headingAnchor" id="H23"><span class="h2">History and examination</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>History </strong>– Important aspects of the history include [<a href="#rid43">43</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Birth weight, length, and OFC and growth trajectory  (<a class="graphic graphic_table graphicRef74157" href="/z/d/graphic/74157.html" rel="external">table 2</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Rate of attainment and/or loss of milestones</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>History of seizures</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>History of predisposing factors for hydrocephalus (eg, meningitis, prematurity with intraventricular hemorrhage)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Family history of consanguinity, large OFC, neurocutaneous disorders, metabolic disorders, and malignancies (the <em>PTEN</em> syndromes [eg, Bannayan-Riley-Ruvalcaba/Cowden syndrome, Proteus syndrome] are associated with breast and thyroid cancers); the family history should include three generations to detect recessive disorders, which may skip a generation. (See  <a class="medical medical_review" href="/z/d/html/16543.html" rel="external">"PTEN hamartoma tumor syndromes, including Cowden syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical examination </strong>– Important aspects of the physical examination of a child with macrocephaly include [<a href="#rid8">8,11,29,43</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>General appearance</strong> – Dysmorphic features may suggest a particular syndrome  (<a class="graphic graphic_table graphicRef75193" href="/z/d/graphic/75193.html" rel="external">table 3</a>). A large cranial vault may be associated with a prominent forehead and a long occipitofrontal diameter (dolichocephaly or scaphocephaly) [<a href="#rid10">10</a>]. Increased width at the cranial base may be associated with mild hypertelorism, down-slanting palpebral fissures, and a relatively small facial area (giving the face a triangular appearance).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>OFC</strong> – The OFC should be measured and plotted on a standard curve. Spurious causes of increased OFC should be excluded (eg, caput succedaneum, cephalohematoma, hair arrangements, abnormal head shape) [<a href="#rid8">8</a>]. (See <a class="local">'Monitoring head growth'</a> above and  <a class="medical medical_review" href="/z/d/html/2845.html" rel="external">"Normal growth patterns in infants and prepubertal children", section on 'Head growth'</a>.)</p><p></p><p class="bulletIndent2">The OFC should be compared with any previous plotted measurements to help determine the onset and progression of increased OFC  (<a class="graphic graphic_table graphicRef74157" href="/z/d/graphic/74157.html" rel="external">table 2</a>). Children with anatomic megalencephaly often are macrocephalic at birth, whereas children with metabolic megalencephaly usually are normocephalic at birth and become macrocephalic in the neonatal period [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Weight and stature trajectories</strong> – The child's weight and length (or height) should also be measured and plotted on standard curves. They should be compared with previous plotted points to assess the growth trajectory. Several macrocephaly syndromes are associated with short or tall stature (overgrowth)  (<a class="graphic graphic_table graphicRef75193" href="/z/d/graphic/75193.html" rel="external">table 3</a>) [<a href="#rid10">10,11</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Head</strong> – In addition to measuring the OFC, examination of the head should include assessment of the fontanelles and auscultation for intracranial bruits (suggestive of arteriovenous malformation). Transillumination of the skull may be performed in infants younger than one year.</p><p></p><p class="bulletIndent2">The size and timing of closure of the fontanelles should be noted. Palpation or shining a light tangentially across the anterior fontanelle should reveal a slightly concave contour when the child is relaxed and in the upright position. Increased intracranial pressure (ICP) may manifest as an enlarged, convex fontanelle or separation of the suture lines. The anterior fontanelle usually closes by 24 months. Persistent enlargement of the anterior fontanelle in children with macrocephaly may be associated with a number of conditions, including [<a href="#rid29">29</a>]: </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Hydrocephalus (see  <a class="medical medical_review" href="/z/d/html/6174.html" rel="external">"Hydrocephalus in children: Physiology, pathogenesis, and etiology"</a> and  <a class="medical medical_review" href="/z/d/html/110031.html" rel="external">"Hydrocephalus in children: Clinical features and diagnosis"</a>) </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Achondroplasia (see  <a class="medical medical_review" href="/z/d/html/103825.html" rel="external">"Achondroplasia"</a>)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Cleidocranial dysplasia (see  <a class="medical medical_review" href="/z/d/html/108252.html" rel="external">"Skeletal dysplasias: Specific disorders"</a> and  <a class="medical medical_review" href="/z/d/html/108252.html" rel="external">"Skeletal dysplasias: Specific disorders", section on 'Cleidocranial dysplasia'</a>)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Rickets (see  <a class="medical medical_review" href="/z/d/html/5856.html" rel="external">"Overview of rickets in children"</a>)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Osteogenesis imperfecta (see  <a class="medical medical_review" href="/z/d/html/2943.html" rel="external">"Osteogenesis imperfecta: An overview"</a>)</p><p></p><p class="bulletIndent2">Transillumination of the skull may be performed in children younger than one year of age but is not commonly used in situations where there is easy access to neuroimaging (eg, ultrasonography of the head). Transillumination of the skull requires a flashlight that has a narrow, opaque, sponge-rubber cuff around the light [<a href="#rid42">42</a>]. An alternative is a "cold" fiberoptic halogen light source. The light is applied to the infant's scalp in a darkened room. Translucency that extends beyond 2 to 2.5 cm (0.8 to 1 inch) in the frontal area and beyond 2 cm (0.8 inches) in the occipital region may be abnormal and indicative of subdural effusion, subdural hematoma, hydrocephalus, hydranencephaly, porencephaly, or increased ICP. Findings on transillumination generally require confirmation with neuroimaging. Transillumination is hampered by cephalohematoma, caput succedaneum, scalp edema, thick black hair, or bony cortex thicker than 1 cm (0.4 inches).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Eyes</strong> – The eyes should be examined for papilledema (suggestive of increased ICP, but may be absent in infants), cataracts, and retinal abnormalities (suggestive of metabolic disease and/or syndromic macrocephaly). (See  <a class="medical medical_review" href="/z/d/html/6270.html" rel="external">"Cataract in children", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Skin</strong> – Examination of the skin for hypopigmented  (<a class="graphic graphic_picture graphicRef91042" href="/z/d/graphic/91042.html" rel="external">picture 3</a>) or hyperpigmented macules, angiomas  (<a class="graphic graphic_picture graphicRef54868" href="/z/d/graphic/54868.html" rel="external">picture 4</a>), shagreen patches  (<a class="graphic graphic_picture graphicRef91045" href="/z/d/graphic/91045.html" rel="external">picture 5</a>), telangiectasia, subcutaneous nodules, lipomas, papillomata  (<a class="graphic graphic_picture graphicRef60952" href="/z/d/graphic/60952.html" rel="external">picture 6</a> and <a class="graphic graphic_table graphicRef75193" href="/z/d/graphic/75193.html" rel="external">table 3</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cardiovascular system</strong> – Signs of congenital heart disease or heart failure (suggestive of a neuro-cardio-facio-cutaneous syndrome)  (<a class="graphic graphic_table graphicRef75193" href="/z/d/graphic/75193.html" rel="external">table 3</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Abdomen</strong> – Hepatosplenomegaly (suggestive of a metabolic or storage disorder).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Musculoskeletal system</strong> – Evidence of skeletal dysplasia (eg, short limbs, absent or hypoplastic clavicles)  (<a class="graphic graphic_table graphicRef65812" href="/z/d/graphic/65812.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/108252.html" rel="external">"Skeletal dysplasias: Specific disorders"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neurologic assessment</strong> – Abnormal tone or deep tendon reflexes. Hypotonia is a common feature of overgrowth syndromes  (<a class="graphic graphic_table graphicRef75193" href="/z/d/graphic/75193.html" rel="external">table 3</a>); spasticity may be a feature of leukodystrophy (eg, Canavan disease, Alexander disease). (See  <a class="medical medical_review" href="/z/d/html/1695.html" rel="external">"Alexander disease"</a>.)</p><p></p><p class="headingAnchor" id="H25"><span class="h2">Assessment of familial macrocephaly</span><span class="headingEndMark"> — </span>The parents' OFC measurements should be obtained if possible. These measurements can be used to calculate a standard score for use with the Weaver curves to determine the genetic contribution to macrocephaly [<a href="#rid17">17</a>].</p><p>The Weaver curve helps to determine whether genetic influences contribute to a child's macrocephaly [<a href="#rid17">17</a>]. A standard score is calculated for the child and each of the parents using the following formula:</p><div class="formulaContainer"><div class="formula"><p>Standard score (SS) = (OFC - mean value)/standard deviation (SD)</p></div></div><p>The mean values and SD for age and sex are listed in the table  (<a class="graphic graphic_table graphicRef61299" href="/z/d/graphic/61299.html" rel="external">table 4</a>). In calculating the parents' standard scores, the mean value and SD for an 18-year-old should be used.</p><p>The average of the parents' SS and the child's SS are plotted on the Weaver curve  (<a class="graphic graphic_figure graphicRef80059" href="/z/d/graphic/80059.html" rel="external">figure 4</a>). A genetic contribution to macrocephaly is suggested if the child's SS is within the range determined by the average parental score, thus permitting the evaluation to be tailored appropriately [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H27"><span class="h2">Neuroimaging</span><span class="headingEndMark"> — </span>Neuroimaging should be obtained in children in whom an expanding lesion is suspected (eg, rapid increase in OFC, for example &gt;2 cm (0.8 inches)/month in an infant &lt;6 months of age) [<a href="#rid42">42</a>]. Among other children, neuroimaging is most helpful (in terms of determining an etiology) for those who have developmental delay but lack features suggestive of a particular syndrome [<a href="#rid43">43,44</a>]. Among children who have features suggestive of a particular syndrome, other laboratory tests (eg, genetic tests) are more helpful in confirming the diagnosis. (See <a class="local">'Other tests'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Approach to imaging</strong> – Radiologic evaluation of macrocephaly may involve radiographs, ultrasonography, CT, or MRI of the head. The optimal imaging strategy permits the detection of significant intracranial pathology and minimizes the potential hazards of radiation and/or sedation [<a href="#rid45">45</a>].</p><p></p><p class="bulletIndent1">The approach to imaging in children with macrocephaly depends upon the age of onset and associated symptoms. Normal infants may experience genetic shifting in OFC percentiles. Thus, a slow shift across one or two major percentile lines (eg, 10<sup>th</sup>, 25<sup>th</sup>, 50<sup>th</sup>, 75<sup>th</sup>, 90<sup>th</sup>) in a developmentally normal child warrants careful clinical observation. If the child's OFC remains within the predicted ranges based on Weaver curves, imaging is not necessary. However, if a child has a dramatic increase in OFC across several major percentile lines or exhibits worrisome neurologic or developmental symptoms, neuroimaging should be undertaken.</p><p></p><p class="bulletIndent1">The timing of closure of the anterior fontanelle is an important factor when considering clinical observation versus imaging. Head ultrasonography, which is noninvasive and does not require sedation, can only be performed in infants with an open fontanelle. Once the anterior fontanelle closes, neuroimaging options include head CT or MRI, each of which may require sedation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Radiographs</strong> – Radiographs may provide evidence of primary skeletal dysplasia. Although they have limited utility in the evaluation of increased ICP, radiographs may demonstrate findings associated with increased ICP, including widening of sutures, prominent convolutional markings on the inner table of the skull ("beaten silver skull"), and erosion of the sella turcica [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ultrasonography</strong> – Head ultrasonography is a reasonable initial study in infants with macrocephaly, normal neurodevelopmental examination, no evidence of increased ICP, and an open anterior fontanelle [<a href="#rid45">45-47</a>]. It may identify ventricular or subarachnoid space enlargement. If head ultrasonography is normal, the infant's OFC and neurodevelopmental status should be monitored closely. (See <a class="local">'Management'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>MRI and CT </strong>– Infants with neurologic abnormalities, progressively enlarging OFC, or increased ICP and a closed anterior fontanelle should be evaluated with MRI or CT. A number of factors affect the choice of neuroimaging study, including the suspected etiology, acuity of symptoms, need for sedation, and availability. MRI generally is preferred to CT because MRI avoids exposure to ionizing radiation. Ultrafast MRI techniques may avoid the need for sedation, which is the major disadvantage of MRI [<a href="#rid48">48</a>]. Consultation with a pediatric neurologist and/or neuroradiologist can be helpful in determining the best study for a particular child.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>MRI</strong> – MRI can delineate the size and position of the ventricles; determine the width of the subarachnoid space; distinguish communicating from noncommunicating hydrocephalus; and identify white matter changes, mass lesions, vascular malformations, subdural fluid collections, and porencephalic cysts [<a href="#rid29">29,43</a>]. MRI with contrast or angiography may be performed to evaluate vascular abnormalities. Ultrafast brain MRI is radiation free and avoids the use of sedation or general anesthesia [<a href="#rid49">49</a>]. If available, it is an option for the evaluation of ventriculomegaly, macrocephaly, and intracranial cysts [<a href="#rid49">49</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>CT</strong> – CT is used primarily in the acute setting for the evaluation of obstructive hydrocephalus. CT also may be used to identify intracranial calcification (which may be present in basal cell nevus syndrome, infection, hypoparathyroidism, or parasitic cysts) [<a href="#rid29">29</a>]. In addition, CT can identify tubers in tuberous sclerosis complex or asymmetry of the cerebral hemispheres in children with linear sebaceous nevus syndrome. (See  <a class="medical medical_review" href="/z/d/html/16902.html" rel="external">"Tuberous sclerosis complex: Management and prognosis", section on 'Brain imaging'</a>.)</p><p></p><p class="headingAnchor" id="H32"><span class="h2">Other tests</span><span class="headingEndMark"> — </span>Additional diagnostic evaluation is directed by the history and physical examination. Consultation with, or referral to, a clinical geneticist can be helpful in determining the appropriate studies.</p><p class="bulletIndent1"><span class="glyph">●</span>Children with syndromic macrocephaly may need evaluation for associated abnormalities (eg, echocardiogram, ophthalmologic examination, abdominal ultrasonography, long bone radiographs) [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children with loss of milestones, degenerative conditions, ASD, or intellectual disability/developmental delay may need metabolic evaluation (eg, urine organic acids and mucopolysaccharidosis screen), genetic studies (eg, for duplications, fragile X syndrome, or <em>PTEN</em> mutation analysis), or electroencephalogram. (See  <a class="medical medical_review" href="/z/d/html/2912.html" rel="external">"Metabolic emergencies in suspected inborn errors of metabolism: Presentation, evaluation, and management", section on 'Initial evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/17216.html" rel="external">"Inborn errors of metabolism: Identifying the specific disorder", section on 'Laboratory evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/16543.html" rel="external">"PTEN hamartoma tumor syndromes, including Cowden syndrome", section on 'Diagnostic criteria'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children with suspected primary skeletal disturbance may need radiographs of the long bones to evaluate cortical thickness.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A skeletal survey is warranted in young children in whom physical abuse is suspected (eg, those with subdural hematoma). (See  <a class="medical medical_review" href="/z/d/html/6534.html" rel="external">"Intracranial subdural hematoma in children: Clinical features, evaluation, and management"</a> and  <a class="medical medical_review" href="/z/d/html/6613.html" rel="external">"Orthopedic aspects of child abuse", section on 'Skeletal survey'</a>.)</p><p></p><p class="headingAnchor" id="H33"><span class="h2">Referral indications</span><span class="headingEndMark"> — </span>Indications for referral depend upon clinical features and the results of the initial evaluation.</p><p class="bulletIndent1"><span class="glyph">●</span>Referral to a clinical geneticist may be helpful in directing additional evaluation in children with syndromic features or suspected metabolic disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children with seizures or abnormal MRI features should be referred to a pediatric neurologist [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children with hydrocephalus or mass lesions may require referral to a neurosurgeon.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children with developmental problems may benefit from referral to a child development team.</p><p></p><p class="headingAnchor" id="H482318471"><span class="h1">EVALUATION OF PRENATAL MACROCEPHALY</span><span class="headingEndMark"> — </span>Prenatally, macrocephaly is diagnosed by ultrasound examination and is defined as head circumference &gt;2 SD above the mean or above the 98<sup>th</sup> percentile for gestational age (as assessed by last menstrual period or femur length). The diagnosis is complicated by limitations in accuracy of head circumference measurements and inconsistency between prenatal and postnatal head circumference growth curves [<a href="#rid50">50</a>]. Although there are reference values for fetal head circumference [<a href="#rid51">51</a>], standards have not been developed for specific populations (eg, based on sex, race/ethnicity).</p><p>The approach to evaluation of prenatal macrocephaly varies according to associated ultrasonographic anomalies, appropriateness of other fetal biometric parameters (eg, length of bones, abdominal circumference) in relation to gestational age, features of the history (eg, consanguinity, familial macrocephaly), and head circumference measurements of parents and siblings [<a href="#rid50">50</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Associated ultrasonographic anomalies (eg, callosal dysgenesis, malformations of cortical development, hypertelorism, enlarged kidneys, polydactyly, hypoplastic long bones) may indicate syndromic macrocephaly  (<a class="graphic graphic_table graphicRef75193" href="/z/d/graphic/75193.html" rel="external">table 3</a>) [<a href="#rid50">50</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Head circumference, abdominal circumference, and long-bone length that are greater than expected for gestational age may indicate an overgrowth syndrome (eg, Sotos syndrome, Weaver syndrome). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fetal head circumference between 2 and 2.5 SD above the mean for gestational age and family members with macrocephaly but no stigmata of autosomal dominant conditions that include macrocephaly  (<a class="graphic graphic_table graphicRef75193" href="/z/d/graphic/75193.html" rel="external">table 3</a>) may indicate familial macrocephaly, although it is unusual for this to present prenatally. (See <a class="local">'Anatomic megalencephaly'</a> above.)</p><p></p><p>Additional evaluation (eg, karyotype, fetal brain MRI) may be obtained if a specific diagnosis is desired to help with pregnancy management. Indications for these evaluations may include [<a href="#rid50">50</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Parental consanguinity</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Family members with macrocephaly and stigmata of autosomal dominant conditions that include macrocephaly  (<a class="graphic graphic_table graphicRef75193" href="/z/d/graphic/75193.html" rel="external">table 3</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Otherwise unexplained fetal macrocephaly (eg, family members with normal head circumference and fetal biometric parameters other than head circumference appropriate for gestational age)</p><p></p><p>The developmental outcome of prenatal macrocephaly depends upon the underlying etiology and associated abnormalities [<a href="#rid52">52</a>].</p><p>Cesarean delivery is indicated in cases in which the head circumference is increased and vaginal delivery is thought not to be possible. The cut-off for determining when a cesarean delivery is indicated will vary with gestational age at delivery, the absolute and relative head circumference, and the size of the maternal pelvis. When the head circumference exceeds 40 cm (16 inches), abdominal delivery should be considered.</p><p class="headingAnchor" id="H34"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>The management of macrocephaly depends upon the etiology.</p><p class="bulletIndent1"><span class="glyph">●</span>Children who have asymptomatic familial megalencephaly do not require treatment.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children who have hydrocephalus may require neurosurgical intervention (eg, placement of a ventriculoperitoneal shunt) to reduce cerebrospinal fluid volume. (See  <a class="medical medical_review" href="/z/d/html/111138.html" rel="external">"Hydrocephalus in children: Management and prognosis", section on 'Management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infants and children who have benign enlargement of the subarachnoid space do not usually require intervention. They should be followed closely for developmental or neurologic problems. Occipitofrontal circumference measurements should be plotted monthly for six months to be certain that the growth is paralleling the normal curve. Repeat imaging is not necessary unless head growth deviates from the curve, the neurologic examination is abnormal, or the development is delayed [<a href="#rid6">6</a>]. (See <a class="local">'Benign enlargement of the subarachnoid space'</a> above and  <a class="medical medical_review" href="/z/d/html/615.html" rel="external">"Developmental-behavioral surveillance and screening in primary care"</a>.)</p><p></p><p class="headingAnchor" id="H1021434615"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/126537.html" rel="external">"Society guideline links: Macrocephaly"</a>.)</p><p class="headingAnchor" id="H35"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring head growth</strong> – Head circumference (occipitofrontal circumference, OFC) should be measured at health maintenance visits between birth and three years of age. OFC measurements are most informative when plotted over time. (See <a class="local">'Monitoring head growth'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definitions</strong> – Macrocephaly is an OFC greater than two standard deviations (SD) above the mean for a given age, sex, and gestation (ie, ≥97<sup>th</sup> percentile). Megalencephaly is enlargement of the brain parenchyma. (See <a class="local">'Definitions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> – Macrocephaly is caused by an increase in size of any of the components of the cranium (brain, cerebrospinal fluid, blood, or bone) or increased intracranial pressure  (<a class="graphic graphic_table graphicRef65812" href="/z/d/graphic/65812.html" rel="external">table 1</a>). (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evaluation for macrocephaly should be initiated when  (<a class="graphic graphic_algorithm graphicRef117172" href="/z/d/graphic/117172.html" rel="external">algorithm 1</a>) (see <a class="local">'Overview of approach'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>A single OFC measurement is abnormal (after confirmation that it was accurately measured), or</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Serial measurements reveal progressive enlargement, or</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For infants age &lt;6 months, when there is an increase in OFC of &gt;2 cm/month (0.8 inches/month)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Factors that increase the urgency and extent of the evaluation of the child with macrocephaly include history of central nervous system trauma or infection; associated symptoms, neurodevelopmental abnormalities, or syndromic features  (<a class="graphic graphic_table graphicRef75193" href="/z/d/graphic/75193.html" rel="external">table 3</a>); and family history  (<a class="graphic graphic_algorithm graphicRef117172" href="/z/d/graphic/117172.html" rel="external">algorithm 1</a>). (See <a class="local">'Overview of approach'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neuroimaging should be obtained in children suspected of having an expanding lesion. Among other children, neuroimaging is most helpful (in terms of determining an etiology) for those who have developmental delay but lack features suggestive of a particular syndrome. The optimal imaging strategy permits the detection of significant intracranial pathology and minimizes the potential hazards of radiation and/or sedation. (See <a class="local">'Neuroimaging'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Additional diagnostic evaluation is directed by the history and physical examination. Consultation with, or referral to, a clinical geneticist can be helpful in determining the appropriate studies. (See <a class="local">'Other tests'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Stoll C. Problems in the diagnosis of fragile X syndrome in young children are still present. Am J Med Genet 2001; 100:110.</a></li><li><a class="nounderline abstract_t">Zvulunov A, Weitz R, Metzker A. Neurofibromatosis type 1 in childhood: evaluation of clinical and epidemiologic features as predictive factors for severity. Clin Pediatr (Phila) 1998; 37:295.</a></li><li><a class="nounderline abstract_t">Furuta T, Tabuchi A, Adachi Y, et al. Primary brain tumors in children under age 3 years. Brain Tumor Pathol 1998; 15:7.</a></li><li><a class="nounderline abstract_t">Tomita T, McLone DG. Brain tumors during the first twenty-four months of life. Neurosurgery 1985; 17:913.</a></li><li class="breakAll">Nard JA. Abnormal head size and shape. In: Common &amp; Chronic Symptoms in Pediatrics, Gartner JC, Zitelli BJ (Eds), Mosby, St. Louis 1997.</li><li class="breakAll">Fenichel GM. Disorders of cranial volume and shape. In: Clinical Pediatric Neurology: A Signs and Symptoms Approach, 5th ed, Elsevier Saunders, Philadelphia 2005. p.353.</li><li><a class="nounderline abstract_t">Grummer-Strawn LM, Reinold C, Krebs NF, Centers for Disease Control and Prevention (CDC). Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States. MMWR Recomm Rep 2010; 59:1.</a></li><li class="breakAll">Varma R, William, SD, Wessel HB. Neurology. In: Atlas of Pediatric Physical Diagnosis, 5th ed, Zitelli BJ, Davis HW (Eds), Mosby Elsevier, Philadelphia 2007. p.563.</li><li><a class="nounderline abstract_t">Opitz JM, Holt MC. Microcephaly: general considerations and aids to nosology. J Craniofac Genet Dev Biol 1990; 10:175.</a></li><li><a class="nounderline abstract_t">Williams CA, Dagli A, Battaglia A. Genetic disorders associated with macrocephaly. Am J Med Genet A 2008; 146A:2023.</a></li><li><a class="nounderline abstract_t">Olney AH. Macrocephaly syndromes. Semin Pediatr Neurol 2007; 14:128.</a></li><li><a class="nounderline abstract_t">Day RE, Schutt WH. Normal children with large heads--benign familial megalencephaly. Arch Dis Child 1979; 54:512.</a></li><li><a class="nounderline abstract_t">Lorber J, Priestley BL. Children with large heads: a practical approach to diagnosis in 557 children, with special reference to 109 children with megalencephaly. Dev Med Child Neurol 1981; 23:494.</a></li><li><a class="nounderline abstract_t">Talebian A, Soltani B, Moravveji A, et al. A study on causes and types of abnormal increase in infants' head circumference in kashan/iran. Iran J Child Neurol 2013; 7:28.</a></li><li><a class="nounderline abstract_t">Strassburg HM. Macrocephaly is not always due to hydrocephalus. J Child Neurol 1989; 4 Suppl:S32.</a></li><li><a class="nounderline abstract_t">DeMyer W. Megalencephaly: types, clinical syndromes, and management. Pediatr Neurol 1986; 2:321.</a></li><li><a class="nounderline abstract_t">Weaver DD, Christian JC. Familial variation of head size and adjustment for parental head circumference. J Pediatr 1980; 96:990.</a></li><li><a class="nounderline abstract_t">Aoki N, Oikawa A, Sakai T. Serial neuroimaging studies in Sotos syndrome (cerebral gigantism syndrome). Neurol Res 1998; 20:149.</a></li><li class="breakAll">Gleeson JG, Dobyns WB, Plawner L, Ashwal S. Congenital structural defects. In: Pediatric Neurology Principles and Practice, 4th ed, Swaiman KF, Ashwal S, Ferriero DM (Eds), Mosby Elsevier, Philadelphia 2006. p.399.</li><li><a class="nounderline abstract_t">Winden KD, Yuskaitis CJ, Poduri A. Megalencephaly and Macrocephaly. Semin Neurol 2015; 35:277.</a></li><li><a class="nounderline abstract_t">Zahl SM, Wester K. Routine measurement of head circumference as a tool for detecting intracranial expansion in infants: what is the gain? A nationwide survey. Pediatrics 2008; 121:e416.</a></li><li><a class="nounderline abstract_t">Alvarez LA, Maytal J, Shinnar S. Idiopathic external hydrocephalus: natural history and relationship to benign familial macrocephaly. Pediatrics 1986; 77:901.</a></li><li><a class="nounderline abstract_t">Ment LR, Duncan CC, Geehr R. Benign enlargement of the subarachnoid spaces in the infant. J Neurosurg 1981; 54:504.</a></li><li><a class="nounderline abstract_t">Kumar R. External hydrocephalus in small children. Childs Nerv Syst 2006; 22:1237.</a></li><li><a class="nounderline abstract_t">Maher CO, Piatt JH Jr, Section on Neurologic Surgery, American Academy of Pediatrics. Incidental findings on brain and spine imaging in children. Pediatrics 2015; 135:e1084.</a></li><li><a class="nounderline abstract_t">Hamza M, Bodensteiner JB, Noorani PA, Barnes PD. Benign extracerebral fluid collections: a cause of macrocrania in infancy. Pediatr Neurol 1987; 3:218.</a></li><li><a class="nounderline abstract_t">Wiig US, Zahl SM, Egge A, et al. Epidemiology of Benign External Hydrocephalus in Norway-A Population-Based Study. Pediatr Neurol 2017; 73:36.</a></li><li><a class="nounderline abstract_t">Zahl SM, Egge A, Helseth E, Wester K. Clinical, Radiological, and Demographic Details of Benign External Hydrocephalus: A Population-Based Study. Pediatr Neurol 2019; 96:53.</a></li><li class="breakAll">Menkes JH, Sarnat HB, Flores-Sarnat L. Malformations of the central nervous system. In: Child Neurology, 7th ed, Menkes JH, Sarnat HB, Maria BL (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.284.</li><li><a class="nounderline abstract_t">Hellbusch LC. Benign extracerebral fluid collections in infancy: clinical presentation and long-term follow-up. J Neurosurg 2007; 107:119.</a></li><li><a class="nounderline abstract_t">Andersson H, Elfverson J, Svendsen P. External hydrocephalus in infants. Childs Brain 1984; 11:398.</a></li><li><a class="nounderline abstract_t">Gherpelli JL, Scaramuzzi V, Manreza ML, Diament AJ. Follow-up study of macrocephalic children with enlargement of the subarachnoid space. Arq Neuropsiquiatr 1992; 50:156.</a></li><li><a class="nounderline abstract_t">Pettit RE, Kilroy AW, Allen JH. Macrocephaly with head growth parallel to normal growth pattern: neurological, developmental, and computerized tomography findings in full-term infants. Arch Neurol 1980; 37:518.</a></li><li><a class="nounderline abstract_t">Nickel RE, Gallenstein JS. Developmental prognosis for infants with benign enlargement of the subarachnoid spaces. Dev Med Child Neurol 1987; 29:181.</a></li><li><a class="nounderline abstract_t">Bosnjak V, Besenski N, Marusić-Della Marina B, Kogler A. Cranial ultrasonography in the evaluation of macrocrania in infancy. Dev Med Child Neurol 1989; 31:66.</a></li><li><a class="nounderline abstract_t">Haws ME, Linscott L, Thomas C, et al. A Retrospective Analysis of the Utility of Head Computed Tomography and/or Magnetic Resonance Imaging in the Management of Benign Macrocrania. J Pediatr 2017; 182:283.</a></li><li><a class="nounderline abstract_t">Ravid S, Maytal J. External hydrocephalus: a probable cause for subdural hematoma in infancy. Pediatr Neurol 2003; 28:139.</a></li><li><a class="nounderline abstract_t">Ghosh PS, Ghosh D. Subdural hematoma in infants without accidental or nonaccidental injury: benign external hydrocephalus, a risk factor. Clin Pediatr (Phila) 2011; 50:897.</a></li><li><a class="nounderline abstract_t">Lago P, Rebsamen S, Clancy RR, et al. MRI, MRA, and neurodevelopmental outcome following neonatal ECMO. Pediatr Neurol 1995; 12:294.</a></li><li><a class="nounderline abstract_t">Canady AI, Fessler RD, Klein MD. Ultrasound abnormalities in term infants on ECMO. Pediatr Neurosurg 1993; 19:202.</a></li><li><a class="nounderline abstract_t">Lorch SA, D'Agostino JA, Zimmerman R, Bernbaum J. "Benign" extra-axial fluid in survivors of neonatal intensive care. Arch Pediatr Adolesc Med 2004; 158:178.</a></li><li class="breakAll">The head. In: Pediatric Diagnosis Interpretation of Symptoms and Signs in Children and Adolescents, 6th ed, Green MG (Ed), WB Saunders, Philadelphia 1998. p.4.</li><li class="breakAll">Firth HV, Hurst JA, Hall JG. Macrocephaly. In: Oxford Desk Reference: Clinical Genetics, 1st ed, Oxford University Press, Oxford 2005. p.162.</li><li><a class="nounderline abstract_t">Sampson MA, Berg AD, Huber JN, Olgun G. Necessity of Intracranial Imaging in Infants and Children With Macrocephaly. Pediatr Neurol 2019; 93:21.</a></li><li><a class="nounderline abstract_t">Smith R, Leonidas JC, Maytal J. The value of head ultrasound in infants with macrocephaly. Pediatr Radiol 1998; 28:143.</a></li><li><a class="nounderline abstract_t">Thomas CN, Kolbe AB, Binkovitz LA, et al. Asymptomatic macrocephaly: to scan or not to scan. Pediatr Radiol 2021; 51:811.</a></li><li class="breakAll">Choosing Wisely. American Academy of Pediatrics. Section on Neurological Surgery. Five things physicians and patients should question. https://www.choosingwisely.org/societies/american-academy-of-pediatrics-section-on-neurological-surgery/ (Accessed on June 28, 2021).</li><li class="breakAll">Choosing Wisely Canada. Pediatric Neurosurgery. March 2017. Available at: https://choosingwiselycanada.org/pediatric-neurosurgery/ (Accessed on May 11, 2019).</li><li><a class="nounderline abstract_t">Tekes A, Senglaub SS, Ahn ES, et al. Ultrafast Brain MRI Can Be Used for Indications beyond Shunted Hydrocephalus in Pediatric Patients. AJNR Am J Neuroradiol 2018; 39:1515.</a></li><li><a class="nounderline abstract_t">Malinger G, Lev D, Ben-Sira L, et al. Can syndromic macrocephaly be diagnosed in utero? Ultrasound Obstet Gynecol 2011; 37:72.</a></li><li><a class="nounderline abstract_t">Kurmanavicius J, Wright EM, Royston P, et al. Fetal ultrasound biometry: 1. Head reference values. Br J Obstet Gynaecol 1999; 106:126.</a></li><li><a class="nounderline abstract_t">Biran-Gol Y, Malinger G, Cohen H, et al. Developmental outcome of isolated fetal macrocephaly. Ultrasound Obstet Gynecol 2010; 36:147.</a></li></ol></div><div id="topicVersionRevision">Topic 2849 Version 41.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11298371" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Problems in the diagnosis of fragile X syndrome in young children are still present.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9597295" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Neurofibromatosis type 1 in childhood: evaluation of clinical and epidemiologic features as predictive factors for severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9879457" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Primary brain tumors in children under age 3 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4080124" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Brain tumors during the first twenty-four months of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4080124" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Brain tumors during the first twenty-four months of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4080124" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Brain tumors during the first twenty-four months of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20829749" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20829749" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2211965" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Microcephaly: general considerations and aids to nosology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18629877" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Genetic disorders associated with macrocephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17980309" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Macrocephaly syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/314781" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Normal children with large heads--benign familial megalencephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7274594" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Children with large heads: a practical approach to diagnosis in 557 children, with special reference to 109 children with megalencephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24665303" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : A study on causes and types of abnormal increase in infants' head circumference in kashan/iran.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2681376" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Macrocephaly is not always due to hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3334205" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Megalencephaly: types, clinical syndromes, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7189556" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Familial variation of head size and adjustment for parental head circumference.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9522351" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Serial neuroimaging studies in Sotos syndrome (cerebral gigantism syndrome).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9522351" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Serial neuroimaging studies in Sotos syndrome (cerebral gigantism syndrome).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26060907" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Megalencephaly and Macrocephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18310161" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Routine measurement of head circumference as a tool for detecting intracranial expansion in infants: what is the gain? A nationwide survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3714384" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Idiopathic external hydrocephalus: natural history and relationship to benign familial macrocephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7205351" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Benign enlargement of the subarachnoid spaces in the infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16555081" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : External hydrocephalus in small children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25825535" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Incidental findings on brain and spine imaging in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3508068" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Benign extracerebral fluid collections: a cause of macrocrania in infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28666559" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Epidemiology of Benign External Hydrocephalus in Norway-A Population-Based Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30808532" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Clinical, Radiological, and Demographic Details of Benign External Hydrocephalus: A Population-Based Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30808532" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Clinical, Radiological, and Demographic Details of Benign External Hydrocephalus: A Population-Based Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18459883" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Benign extracerebral fluid collections in infancy: clinical presentation and long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6510047" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : External hydrocephalus in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1308383" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Follow-up study of macrocephalic children with enlargement of the subarachnoid space.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7417044" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Macrocephaly with head growth parallel to normal growth pattern: neurological, developmental, and computerized tomography findings in full-term infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3582787" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Developmental prognosis for infants with benign enlargement of the subarachnoid spaces.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2920873" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Cranial ultrasonography in the evaluation of macrocrania in infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27989412" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : A Retrospective Analysis of the Utility of Head Computed Tomography and/or Magnetic Resonance Imaging in the Management of Benign Macrocrania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12699866" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : External hydrocephalus: a probable cause for subdural hematoma in infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21576186" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Subdural hematoma in infants without accidental or nonaccidental injury: benign external hydrocephalus, a risk factor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7546003" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : MRI, MRA, and neurodevelopmental outcome following neonatal ECMO.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8329305" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Ultrasound abnormalities in term infants on ECMO.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14757610" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : "Benign" extra-axial fluid in survivors of neonatal intensive care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14757610" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : "Benign" extra-axial fluid in survivors of neonatal intensive care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14757610" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : "Benign" extra-axial fluid in survivors of neonatal intensive care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30704866" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Necessity of Intracranial Imaging in Infants and Children With Macrocephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9561530" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The value of head ultrasound in infants with macrocephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33399982" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Asymptomatic macrocephaly: to scan or not to scan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33399982" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Asymptomatic macrocephaly: to scan or not to scan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33399982" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Asymptomatic macrocephaly: to scan or not to scan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30002051" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Ultrafast Brain MRI Can Be Used for Indications beyond Shunted Hydrocephalus in Pediatric Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20734344" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Can syndromic macrocephaly be diagnosed in utero?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10426678" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Fetal ultrasound biometry: 1. Head reference values.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20178112" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Developmental outcome of isolated fetal macrocephaly.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
